W. K. Patterson

799 total citations
10 papers, 76 citations indexed

About

W. K. Patterson is a scholar working on Oncology, Oral Surgery and Pharmacology. According to data from OpenAlex, W. K. Patterson has authored 10 papers receiving a total of 76 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Oral Surgery and 2 papers in Pharmacology. Recurrent topics in W. K. Patterson's work include Cancer Diagnosis and Treatment (3 papers), Oral and Maxillofacial Pathology (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). W. K. Patterson is often cited by papers focused on Cancer Diagnosis and Treatment (3 papers), Oral and Maxillofacial Pathology (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). W. K. Patterson collaborates with scholars based in Australia and Barbados. W. K. Patterson's co-authors include Timothy Price, Ian Olver, Ken Pittman, Christos S. Karapetis, Dusan Kotasek, Dorothy Keefe, Bogda Koczwara, Amanda Townsend, Francis Parnis and Robert Sage and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

W. K. Patterson

10 papers receiving 72 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. K. Patterson Australia	6	53	26	24	12	10	10	76
Yoshitaka Utsumi Japan	5	19 0.4×	12 0.5×	21 0.9×	7 0.6×	3 0.3×	17	77
Gelareh Zadeh Canada	4	11 0.2×	12 0.5×	29 1.2×	49 4.1×		13	74
Andrew Kedziora Australia	4	66 1.2×	2 0.1×	45 1.9×	12 1.0×	4 0.4×	4	103
Mara Dolcino Italy	4	33 0.6×	4 0.2×	6 0.3×	21 1.8×		5	76
Ruzanna Papyan Armenia	4	9 0.2×	12 0.5×	9 0.4×	18 1.5×		14	55
Zaina P. Qureshi United States	4	25 0.5×		32 1.3×	7 0.6×	9 0.9×	32	95
Béla Pikó Hungary	5	59 1.1×		7 0.3×	19 1.6×	9 0.9×	20	89
Lamya Hamad United States	6	50 0.9×		9 0.4×	13 1.1×	3 0.3×	11	92
Grace Cherry United States	5	57 1.1×		10 0.4×	16 1.3×	8 0.8×	6	83
Guo Ren China	4	37 0.7×		28 1.2×	19 1.6×	11 1.1×	6	100

Countries citing papers authored by W. K. Patterson

Since Specialization

Citations

This map shows the geographic impact of W. K. Patterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. K. Patterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. K. Patterson more than expected).

Fields of papers citing papers by W. K. Patterson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. K. Patterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. K. Patterson. The network helps show where W. K. Patterson may publish in the future.

Co-authorship network of co-authors of W. K. Patterson

This figure shows the co-authorship network connecting the top 25 collaborators of W. K. Patterson. A scholar is included among the top collaborators of W. K. Patterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. K. Patterson. W. K. Patterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Pittman, Ken, et al.. (2015). Can maintenance trastuzumab be stopped in patients with HER2-positive metastatic breast cancer?. BMJ Case Reports. 2015. bcr2014207750–bcr2014207750. 6 indexed citations

Pittman, K., Michael P. Brown, Bogda Koczwara, et al.. (2011). Gemcitabine and carboplatin in carcinoma of unknown primary site (CUP) in elderly patients: Analysis of a phase 2 Adelaide Cancer Trials and Education Collaborative (ACTEC) study. Journal of Geriatric Oncology. 2(4). 233–238. 1 indexed citations

Sukumaran, Shawgi, et al.. (2009). A phase I study to determine the safety, tolerability and maximum tolerated dose of green-lipped mussel (Perna canaliculus) lipid extract, in patients with advanced prostate and breast cancer. Annals of Oncology. 21(5). 1089–1093. 8 indexed citations

Boer, Renate de, et al.. (2008). Pegfilgrastim and darbepoetin alfa as haematopoietic support for adjuvant dose dense doxorubicin + cyclophosphamide-paclitaxel in early stage breast cancer patients – results from the ACCELERATE study. European Journal of Cancer Supplements. 6(7). 128–128. 1 indexed citations

Price, Timothy, K. Pittman, W. K. Patterson, et al.. (2008). Management and Survival Trends in Advanced Colorectal Cancer. Clinical Oncology. 20(8). 626–630. 6 indexed citations

Pittman, Ken, Ian Olver, Bogda Koczwara, et al.. (2006). Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study. British Journal of Cancer. 95(10). 1309–1313. 32 indexed citations

Pittman, Ken, Ian Olver, Christos S. Karapetis, et al.. (2005). Mulicenter phase II study of gemcitabine and carboplatin combination therapy for patients with metastatic carcinoma of unknown primary site: final results. Journal of Clinical Oncology. 23(16_suppl). 8142–8142. 1 indexed citations

Karapetis, Christos S., W. K. Patterson, Ken Pittman, Dusan Kotasek, & Robert Sage. (1999). Treatment of metastatic breast cancer with continuous infusional 5 fluorouracil. Australian and New Zealand Journal of Medicine. 29(4). 517–522. 5 indexed citations

Price, Timothy, W. K. Patterson, & Ian Olver. (1998). Rifampicin as treatment for pruritus in malignant cholestasis. Supportive Care in Cancer. 6(6). 533–535. 14 indexed citations

10.

Patterson, W. K., Robert Sage, & Dorothy Keefe. (1994). Haemorrhagic gastritis in two patients treated with all‐trans‐retinoic acid in acute promyelocytic leukaemia. Australian and New Zealand Journal of Medicine. 24(3). 314–315. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact